[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
Editorial Policies::
Articles archive::
For Authors::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Contact Us
:: Volume 26, Issue 4 (10-2014) ::
J Iran Dent Assoc 2014, 26(4): 226-232 Back to browse issues page
Adjunctive Low-Dose Aspirin plus Omega-3 Fatty Acid versus Low-Dose Doxycycline on Chronic Periodontitis
Shirin Zahra Farhad1 , Shahram Amini1 , Atefeh Mahdian2 , Mehrdad Barkatain3 , Morvarid Mafi * 4
1- Assistant Professor, Department of Periodontics, School of Dentistry, Khorasgan Islamic Azad University. Isfahan, Iran
2- Dentist, Private Office, Isfahan, Iran
3- Assistant Professor, Department of Restorative Dentistry, School of Dentistry, Khorasgan Islamic Azad University. Isfahan, Iran
4- Assistant Professor, Department of Periodontics, School of Dentistry, Ahwaz University of Medical Sciences. Ahwaz, Iran , Morvarid.Ltk@gmail.com
Abstract:   (4814 Views)

Background and Aim: Host modulation therapy (HMT) has been considered as a new modality for treatment of periodontal disease. Omega-3 fatty acid has shown inhibitory and anti-inflammatory properties in treatment of inflammatory conditions such as perio-dontitis. This study compared the efficacy of omega-3 fatty acid and low-dose aspirin with doxycycline in treatment of chronic periodontitis.

Materials and Methods: Forty-five patients with chronic periodontitis were selected and their clinical periodontal parameters were measured. They received phase I of periodontal therapy and were randomly divided into three groups. Each group randomly received one of the following daily drug regimens: omega-3 fatty acid plus aspirin (80mg), doxycy-cline (20mg) and the placebo (control). Clinical parameters were measured again after six weeks. Wilcoxon test, paired t-test, Kruskal–Wallis test and one-way ANOVA were used to analyze the data.

Results: The mean values of bleeding on probing (BOP), periodontal pocket depth (PPD) and clinical attachment loss (CAL) in both test groups decreased significantly compared to the placebo group (p<0.05). The reductions in the omega-3 group were significantly greater than those in the doxycycline group (p<0.05).

Conclusion: Omega-3 fatty acid can improve clinical parameters of periodontal disease, even better than doxycycline, which is routinely used for HMT.

Keywords: Chronic periodontitis, Omega-3 fatty acid, Doxycycline
Full-Text [PDF 169 kb]   (2167 Downloads)    
Type of Study: Original | Subject: Periodontology
References
1. Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontol. 1986 May;13(5):418-30.
2. Newman MG, Takei HH, Klokkevold PR, Carranza FA. Carranza’s clinical periodontolo-gy. 11thed. Missouri: Elsevier Saunders; 2012,160.
3. Kantarci A, Van Dyke TE. Lipoxin signaling in neutrophils and their role in periodontal disease. Prostagland Leuk Essent Fat Acid. 2005 Sept-Oct; 73(3-4):289-99.
4. Van Dyke TE, Serhan CN. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J Dent Res. 2003 Feb; 82(2):82-90.
5. Iwasaki M, Yoshihara A, Moynihan P, Watanabe R, Taylor GW, Miyazaki H. Longitudinal relationship between dietary ω-3 fatty acids and periodontal disease. Nutrition. 2010 Nov -Dec; 26 (11-12):1105-9.
6. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol. 2005;32 Suppl 6:108-29.
7. Bhatavadekar NB, Williams RC. New directions in host modulation for the management of periodontal disease. J Clin Periodontol. 2009 Feb; 36(2):124-6.
8. Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis A review. J Clin Periodontol. 2004 Sept; 31(9):697-707.
9. Fleming T. PDR for herbal Medicines. 1st ed. Montvale: Medical Econnomics; 1998. 875-9.
10. Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodon-tal disease. SDD Clinical Research Team. Ann N Y Acad Sci. 1999 Jun 30;878:335-46.
11. Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J Clin Peri-odontol. 2001 Aug;28(8):782-9.
12. Crout RJ, Lee HM, Schroeder K, Crout H, Ramamurthy NS, Wiener M, et al. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol. 1996 May;67(5):506-14.
13. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, et al. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a pro-posed new mechanism of action. J Periodontal Res. 1983 Sept;18(5):516-26.
14. Kesavalu L, Vasudevan B, Raghu B, Browning E, Dawson D, Novak JM, et al. Omega-3 fatty acid effect on alveolar bone loss in rats. J Dent Res. 2006 Jul;85(7):648-52.
15. Naqvi AZ, Buettner C, Phillips RS, Davis RB, Mukamal KJ. n-3 fatty acids and periodontitis in US adults. J Am Diet Assoc. 2010 Nov; 110(11): 1669-75.
16. Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygen-ase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from ome-ga-3 polyunsaturated fatty acids. Biochem Biophys Res Com. 2005 Dec 9;338(1):149-57.
17. Faizuddin M, Tarannum F, Korla N, Swamy S. Association between long-term aspirin use and periodontal attachment level in humans: a cross-sectional investigation. Aust Dent J. 2012 Mar; 57(1):45-50.
18. Elkhouli AM. The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study). Elkhouli AM. J Periodontal Res. 2011 Apr; 46(2): 261-8.
19. Bendyk A, Marino V, Zilm PS, Howe P, Bartold PM. Effect of dietary omega-3 polyunsaturated fatty acids on experimental periodontitis in the mouse. J Periodontal Res. 2009 Apr; 44(2):211-6.
20. Golub LM, Suomalainen K, Sorsa T. Host mod-ulation with tetracyclines and their chemically modified analogues. Curr Opin Dent. 1992 Mar; 2: 80-90.
21. Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, et al. Collagenase-3 (ma-trix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic in-flammation. Am J Pathol. 1998 Jun;152(6):1489-99.
22. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation.J Biol Chem. 2003 Apr 25;278(17):14677-87.
23. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008 May;8(5):349-61.
24. El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, et al. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodon-tol. 2010 Nov; 81(11):1635-43.
25. Caton J, Ryan ME. Clinical studies on the man-agement of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Pharmacol Res. 2011 Feb;63(2):114-20.
26. Golub LM, Lee HM, Stoner JA, Reinhardt RA, Sorsa T, Goren AD, et al. Doxycycline effects on serum bone biomarkers in post-menopausal women. J Dent Res. 2010 Jun; 89(6):644-9.
27. Payne JB, Golub LM. Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinic. Phar-macol Res. 2011 Feb;63(2):121-9.
28. Tüter G, Kurtiş B, Serdar M, Aykan T, Okyay K, Yücel A,et al. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol. 2007Aug; 34(8):673-81.
29. Akalin FA, Baltacioğlu E, Sengün D, Hekimoğlu S, Taşkin M, Etikan I, et al. A comparative evaluation of the clinical effects of systemic and local doxycycline in the treatment of chronic periodontitis. J Oral Sci. 2004 Mar; 46(1): 25-35.
30. Novak MJ, Johns LP, Miller RC, Bradshaw MH. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol. 2002 Jul; 73(7):762-9.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farhad S Z, Amini S, Mahdian A, Barkatain M, Mafi M. Adjunctive Low-Dose Aspirin plus Omega-3 Fatty Acid versus Low-Dose Doxycycline on Chronic Periodontitis. J Iran Dent Assoc 2014; 26 (4) :226-232
URL: http://jida.ir/article-1-1716-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 26, Issue 4 (10-2014) Back to browse issues page
Journal of Iranian Dental Association

AWT IMAGE

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4645